These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 8656699)
1. MDR1, MRP, topoisomerase IIalpha/beta, and cyclin A gene expression in acute and chronic leukemias. Beck J; Niethammer D; Gekeler V Leukemia; 1996 Jul; 10 Suppl 3():S39-S45. PubMed ID: 8656699 [TBL] [Abstract][Full Text] [Related]
2. Expression of mdr1, mrp, topoisomerase II alpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias. Beck J; Handgretinger R; Dopfer R; Klingebiel T; Niethammer D; Gekeler V Br J Haematol; 1995 Feb; 89(2):356-63. PubMed ID: 7873386 [TBL] [Abstract][Full Text] [Related]
3. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients. Ross DD; Doyle LA; Schiffer CA; Lee EJ; Grant CE; Cole SP; Deeley RG; Yang W; Tong Y Leukemia; 1996 Jan; 10(1):48-55. PubMed ID: 8558937 [TBL] [Abstract][Full Text] [Related]
4. High mdr1- and mrp-, but low topoisomerase II alpha-gene expression in B-cell chronic lymphocytic leukaemias. Beck J; Niethammer D; Gekeler V Cancer Lett; 1994 Oct; 86(1):135-42. PubMed ID: 7954350 [TBL] [Abstract][Full Text] [Related]
5. Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias. Gekeler V; Frese G; Noller A; Handgretinger R; Wilisch A; Schmidt H; Muller CP; Dopfer R; Klingebiel T; Diddens H Br J Cancer; 1992 Sep; 66(3):507-17. PubMed ID: 1355660 [TBL] [Abstract][Full Text] [Related]
6. Expression of PKC isozyme and MDR-associated genes in primary and relapsed state AML. Beck J; Handgretinger R; Klingebiel T; Dopfer R; Schaich M; Ehninger G; Niethammer D; Gekeler V Leukemia; 1996 Mar; 10(3):426-33. PubMed ID: 8642857 [TBL] [Abstract][Full Text] [Related]
7. Expression of the human major vault protein LRP in acute myeloid leukemia. Hart SM; Ganeshaguru K; Scheper RJ; Prentice HG; Hoffbrand AV; Mehta AB Exp Hematol; 1997 Nov; 25(12):1227-32. PubMed ID: 9357965 [TBL] [Abstract][Full Text] [Related]
8. Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKC eta with MDR1, MRP and LRP gene expression. Beck J; Bohnet B; Brügger D; Bader P; Dietl J; Scheper RJ; Kandolf R; Liu C; Niethammer D; Gekeler V Br J Cancer; 1998; 77(1):87-91. PubMed ID: 9459150 [TBL] [Abstract][Full Text] [Related]
9. Topoisomerase IIalpha and other drug resistance markers in advanced non-small cell lung cancer. Dingemans AC; van Ark-Otte J; Span S; Scagliotti GV; van der Valk P; Postmus PE; Giaccone G Lung Cancer; 2001 May; 32(2):117-28. PubMed ID: 11325482 [TBL] [Abstract][Full Text] [Related]
10. Expression of multidrug resistance-associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia. Zhou DC; Zittoun R; Marie JP Leukemia; 1995 Oct; 9(10):1661-6. PubMed ID: 7564506 [TBL] [Abstract][Full Text] [Related]
11. Expression of the multidrug resistance-associated protein (MRP) in acute leukaemia. Hart SM; Ganeshaguru K; Hoffbrand AV; Prentice HG; Mehta AB Leukemia; 1994 Dec; 8(12):2163-8. PubMed ID: 7808005 [TBL] [Abstract][Full Text] [Related]
12. Five putative drug resistance parameters (MDR1/P-glycoprotein, MDR-associated protein, glutathione-S-transferase, bcl-2 and topoisomerase IIalpha) in 57 newly diagnosed acute myeloid leukaemias. Swiss Group for Clinical Cancer Research (SAKK). Lohri A; van Hille B; Bacchi M; Fopp M; Joncourt F; Reuter J; Cerny T; Fey MF; Herrmann R Eur J Haematol; 1997 Oct; 59(4):206-15. PubMed ID: 9338618 [TBL] [Abstract][Full Text] [Related]
13. Expression of drug resistance-related genes in head and neck squamous cell carcinomas and normal mucosa. Hirata S; Katoh O; Oguri T; Watanabe H; Yajin K Jpn J Cancer Res; 2000 Jan; 91(1):84-90. PubMed ID: 10744048 [TBL] [Abstract][Full Text] [Related]
14. Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization. Wessel I; Jensen PB; Falck J; Mirski SE; Cole SP; Sehested M Cancer Res; 1997 Oct; 57(20):4451-4. PubMed ID: 9377550 [TBL] [Abstract][Full Text] [Related]
15. Expression patterns of multidrug-resistance (MDR1), multidrug resistance-associated protein (MRP),glutathione-S-transferase-pi (GST-pi) and DNA topoisomerase II (Topo II) genes in renal cell carcinomas and normal kidney. Kim WJ; Kakehi Y; Kinoshita H; Arao S; Fukumoto M; Yoshida O J Urol; 1996 Aug; 156(2 Pt 1):506-11. PubMed ID: 8683726 [TBL] [Abstract][Full Text] [Related]
16. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells. Svirnovski AI; Shman TV; Serhiyenka TF; Savitski VP; Smolnikova VV; Fedasenka UU Hematology; 2009 Aug; 14(4):204-12. PubMed ID: 19635183 [TBL] [Abstract][Full Text] [Related]
17. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833. Beketic-Oreskovic L; Durán GE; Chen KG; Dumontet C; Sikic BI J Natl Cancer Inst; 1995 Nov; 87(21):1593-602. PubMed ID: 7563202 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia. Schneider E; Cowan KH; Bader H; Toomey S; Schwartz GN; Karp JE; Burke PJ; Kaufmann SH Blood; 1995 Jan; 85(1):186-93. PubMed ID: 7528566 [TBL] [Abstract][Full Text] [Related]
19. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines. Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314 [TBL] [Abstract][Full Text] [Related]
20. Drug-induced changes in the expression of MDR-associated genes: investigations on cultured cell lines and chemotherapeutically treated leukemias. Gekeler V; Beck J; Noller A; Wilisch A; Frese G; Neumann M; Handgretinger R; Ehninger G; Probst H; Niethammer D Ann Hematol; 1994; 69 Suppl 1():S19-24. PubMed ID: 7914748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]